nodes	percent_of_prediction	percent_of_DWPC	metapath
Trandolapril—coronary artery disease—atherosclerosis	0.563	1	CtDrD
Trandolapril—ACE—atherosclerosis	0.258	1	CbGaD
Trandolapril—CES1—Phase I biotransformations, non P450—PON3—atherosclerosis	0.0128	0.306	CbGpPWpGaD
Trandolapril—ACE—thoracic aorta—atherosclerosis	0.00926	0.198	CbGeAlD
Trandolapril—CES1—Phase I biotransformations, non P450—PON2—atherosclerosis	0.00823	0.197	CbGpPWpGaD
Trandolapril—ACE—renal artery—atherosclerosis	0.00751	0.161	CbGeAlD
Trandolapril—CES1—Irinotecan Pathway—NPC1—atherosclerosis	0.00618	0.148	CbGpPWpGaD
Trandolapril—ACE—arteriole—atherosclerosis	0.00604	0.129	CbGeAlD
Trandolapril—CES1—Phase I biotransformations, non P450—PON1—atherosclerosis	0.00432	0.104	CbGpPWpGaD
Trandolapril—ACE—tunica intima—atherosclerosis	0.00428	0.0917	CbGeAlD
Trandolapril—ACE—vein—atherosclerosis	0.0036	0.0771	CbGeAlD
Trandolapril—ACE—umbilical vein—atherosclerosis	0.00261	0.056	CbGeAlD
Trandolapril—ACE—hindlimb—atherosclerosis	0.00239	0.0512	CbGeAlD
Trandolapril—ACE—appendage—atherosclerosis	0.00205	0.0439	CbGeAlD
Trandolapril—ACE—artery—atherosclerosis	0.00147	0.0314	CbGeAlD
Trandolapril—ACE—endothelium—atherosclerosis	0.00124	0.0265	CbGeAlD
Trandolapril—ACE—blood vessel—atherosclerosis	0.00114	0.0245	CbGeAlD
Trandolapril—ACE—ACE Inhibitor Pathway—KNG1—atherosclerosis	0.00108	0.0259	CbGpPWpGaD
Trandolapril—ACE—ACE Inhibitor Pathway—AGTR1—atherosclerosis	0.00107	0.0257	CbGpPWpGaD
Trandolapril—CES1—connective tissue—atherosclerosis	0.00088	0.0188	CbGeAlD
Trandolapril—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—atherosclerosis	0.000793	0.019	CbGpPWpGaD
Trandolapril—CES1—cardiovascular system—atherosclerosis	0.000766	0.0164	CbGeAlD
Trandolapril—ACE—ACE Inhibitor Pathway—AGT—atherosclerosis	0.000755	0.0181	CbGpPWpGaD
Trandolapril—CES1—adipose tissue—atherosclerosis	0.000675	0.0145	CbGeAlD
Trandolapril—ACE—connective tissue—atherosclerosis	0.000585	0.0125	CbGeAlD
Trandolapril—ACE—Peptide hormone metabolism—PLA2G7—atherosclerosis	0.000581	0.0139	CbGpPWpGaD
Trandolapril—ACE—ACE Inhibitor Pathway—NOS3—atherosclerosis	0.000554	0.0133	CbGpPWpGaD
Trandolapril—Aspartame—TRPV1—atherosclerosis	0.000546	0.169	CrCbGaD
Trandolapril—ACE—cardiovascular system—atherosclerosis	0.000509	0.0109	CbGeAlD
Trandolapril—CES1—liver—atherosclerosis	0.000473	0.0101	CbGeAlD
Trandolapril—ACE—adipose tissue—atherosclerosis	0.000449	0.00962	CbGeAlD
Trandolapril—SLC15A1—liver—atherosclerosis	0.000439	0.00941	CbGeAlD
Trandolapril—CES1—Fluoropyrimidine Activity—MTHFR—atherosclerosis	0.000428	0.0103	CbGpPWpGaD
Trandolapril—ACE—ACE Inhibitor Pathway—TGFB1—atherosclerosis	0.000367	0.00879	CbGpPWpGaD
Trandolapril—ACE—Peptide hormone metabolism—GHRL—atherosclerosis	0.000339	0.00814	CbGpPWpGaD
Trandolapril—ACE—liver—atherosclerosis	0.000315	0.00675	CbGeAlD
Trandolapril—Fosinopril—ACE—atherosclerosis	0.000284	0.0877	CrCbGaD
Trandolapril—CES1—E2F transcription factor network—SIRT1—atherosclerosis	0.000267	0.00641	CbGpPWpGaD
Trandolapril—Perindopril—ACE—atherosclerosis	0.000232	0.0715	CrCbGaD
Trandolapril—Spirapril—ACE—atherosclerosis	0.000229	0.0707	CrCbGaD
Trandolapril—Moexipril—ACE—atherosclerosis	0.00022	0.0678	CrCbGaD
Trandolapril—Mitiglinide—PPARG—atherosclerosis	0.000219	0.0675	CrCbGaD
Trandolapril—Benazepril—MTHFR—atherosclerosis	0.000218	0.0673	CrCbGaD
Trandolapril—ACE—Peptide hormone metabolism—AGT—atherosclerosis	0.000208	0.005	CbGpPWpGaD
Trandolapril—Quinapril—ACE—atherosclerosis	0.000204	0.063	CrCbGaD
Trandolapril—Cilazapril—ACE—atherosclerosis	0.000204	0.063	CrCbGaD
Trandolapril—Lisinopril—ACE—atherosclerosis	0.000204	0.063	CrCbGaD
Trandolapril—ACE—Peptide hormone metabolism—LEP—atherosclerosis	0.000204	0.0049	CbGpPWpGaD
Trandolapril—Ramipril—ACE—atherosclerosis	0.000198	0.061	CrCbGaD
Trandolapril—Oedema peripheral—Niacin—atherosclerosis	0.000194	0.00222	CcSEcCtD
Trandolapril—Hepatitis—Pravastatin—atherosclerosis	0.000194	0.00222	CcSEcCtD
Trandolapril—Back pain—Lovastatin—atherosclerosis	0.000193	0.00221	CcSEcCtD
Trandolapril—Flatulence—Ezetimibe—atherosclerosis	0.000193	0.0022	CcSEcCtD
Trandolapril—Pharyngitis—Pravastatin—atherosclerosis	0.000193	0.0022	CcSEcCtD
Trandolapril—Muscle spasms—Lovastatin—atherosclerosis	0.000192	0.00219	CcSEcCtD
Trandolapril—Infection—Rosuvastatin—atherosclerosis	0.000191	0.00218	CcSEcCtD
Trandolapril—Visual impairment—Niacin—atherosclerosis	0.00019	0.00217	CcSEcCtD
Trandolapril—Alopecia—Simvastatin—atherosclerosis	0.00019	0.00217	CcSEcCtD
Trandolapril—Back pain—Ezetimibe—atherosclerosis	0.000189	0.00216	CcSEcCtD
Trandolapril—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000189	0.00215	CcSEcCtD
Trandolapril—Muscle spasms—Ezetimibe—atherosclerosis	0.000188	0.00215	CcSEcCtD
Trandolapril—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000188	0.00215	CcSEcCtD
Trandolapril—Mental disorder—Simvastatin—atherosclerosis	0.000188	0.00215	CcSEcCtD
Trandolapril—Visual impairment—Pravastatin—atherosclerosis	0.000187	0.00214	CcSEcCtD
Trandolapril—Ill-defined disorder—Lovastatin—atherosclerosis	0.000185	0.00212	CcSEcCtD
Trandolapril—Eye disorder—Niacin—atherosclerosis	0.000184	0.0021	CcSEcCtD
Trandolapril—Flatulence—Simvastatin—atherosclerosis	0.000184	0.0021	CcSEcCtD
Trandolapril—Tinnitus—Niacin—atherosclerosis	0.000184	0.0021	CcSEcCtD
Trandolapril—Erythema multiforme—Pravastatin—atherosclerosis	0.000183	0.00209	CcSEcCtD
Trandolapril—Dysgeusia—Simvastatin—atherosclerosis	0.000183	0.00209	CcSEcCtD
Trandolapril—Flushing—Niacin—atherosclerosis	0.000183	0.00209	CcSEcCtD
Trandolapril—Angioedema—Lovastatin—atherosclerosis	0.000182	0.00208	CcSEcCtD
Trandolapril—Ill-defined disorder—Ezetimibe—atherosclerosis	0.000182	0.00208	CcSEcCtD
Trandolapril—Anaemia—Ezetimibe—atherosclerosis	0.000181	0.00207	CcSEcCtD
Trandolapril—Tinnitus—Pravastatin—atherosclerosis	0.000181	0.00207	CcSEcCtD
Trandolapril—Malaise—Lovastatin—atherosclerosis	0.00018	0.00206	CcSEcCtD
Trandolapril—Flushing—Pravastatin—atherosclerosis	0.00018	0.00206	CcSEcCtD
Trandolapril—Cardiac disorder—Pravastatin—atherosclerosis	0.00018	0.00206	CcSEcCtD
Trandolapril—Muscle spasms—Simvastatin—atherosclerosis	0.00018	0.00205	CcSEcCtD
Trandolapril—Vertigo—Lovastatin—atherosclerosis	0.000179	0.00205	CcSEcCtD
Trandolapril—Angioedema—Ezetimibe—atherosclerosis	0.000179	0.00204	CcSEcCtD
Trandolapril—Angiopathy—Niacin—atherosclerosis	0.000179	0.00204	CcSEcCtD
Trandolapril—Leukopenia—Lovastatin—atherosclerosis	0.000179	0.00204	CcSEcCtD
Trandolapril—Benazepril—ACE—atherosclerosis	0.000178	0.0548	CrCbGaD
Trandolapril—Malaise—Ezetimibe—atherosclerosis	0.000177	0.00202	CcSEcCtD
Trandolapril—Arrhythmia—Niacin—atherosclerosis	0.000176	0.00201	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000175	0.002	CcSEcCtD
Trandolapril—ACE—Peptide hormone metabolism—INS—atherosclerosis	0.000174	0.00418	CbGpPWpGaD
Trandolapril—Alopecia—Niacin—atherosclerosis	0.000174	0.00199	CcSEcCtD
Trandolapril—Insomnia—Rosuvastatin—atherosclerosis	0.000174	0.00199	CcSEcCtD
Trandolapril—Ill-defined disorder—Simvastatin—atherosclerosis	0.000173	0.00198	CcSEcCtD
Trandolapril—Arrhythmia—Pravastatin—atherosclerosis	0.000173	0.00198	CcSEcCtD
Trandolapril—Palpitations—Ezetimibe—atherosclerosis	0.000173	0.00198	CcSEcCtD
Trandolapril—Paraesthesia—Rosuvastatin—atherosclerosis	0.000173	0.00197	CcSEcCtD
Trandolapril—Anaemia—Simvastatin—atherosclerosis	0.000173	0.00197	CcSEcCtD
Trandolapril—Malnutrition—Niacin—atherosclerosis	0.000172	0.00196	CcSEcCtD
Trandolapril—Alopecia—Pravastatin—atherosclerosis	0.000171	0.00196	CcSEcCtD
Trandolapril—Cough—Ezetimibe—atherosclerosis	0.000171	0.00195	CcSEcCtD
Trandolapril—Angioedema—Simvastatin—atherosclerosis	0.000171	0.00195	CcSEcCtD
Trandolapril—Arthralgia—Lovastatin—atherosclerosis	0.00017	0.00194	CcSEcCtD
Trandolapril—Myalgia—Lovastatin—atherosclerosis	0.00017	0.00194	CcSEcCtD
Trandolapril—Chest pain—Lovastatin—atherosclerosis	0.00017	0.00194	CcSEcCtD
Trandolapril—Anxiety—Lovastatin—atherosclerosis	0.000169	0.00193	CcSEcCtD
Trandolapril—Dyspepsia—Rosuvastatin—atherosclerosis	0.000169	0.00193	CcSEcCtD
Trandolapril—Flatulence—Niacin—atherosclerosis	0.000169	0.00193	CcSEcCtD
Trandolapril—ACE—Peptide hormone metabolism—IGF1—atherosclerosis	0.000169	0.00405	CbGpPWpGaD
Trandolapril—Malaise—Simvastatin—atherosclerosis	0.000168	0.00192	CcSEcCtD
Trandolapril—Discomfort—Lovastatin—atherosclerosis	0.000168	0.00192	CcSEcCtD
Trandolapril—Vertigo—Simvastatin—atherosclerosis	0.000168	0.00192	CcSEcCtD
Trandolapril—Leukopenia—Simvastatin—atherosclerosis	0.000167	0.00191	CcSEcCtD
Trandolapril—Myalgia—Ezetimibe—atherosclerosis	0.000167	0.0019	CcSEcCtD
Trandolapril—Chest pain—Ezetimibe—atherosclerosis	0.000167	0.0019	CcSEcCtD
Trandolapril—Arthralgia—Ezetimibe—atherosclerosis	0.000167	0.0019	CcSEcCtD
Trandolapril—Flatulence—Pravastatin—atherosclerosis	0.000166	0.0019	CcSEcCtD
Trandolapril—Dry mouth—Lovastatin—atherosclerosis	0.000166	0.0019	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000166	0.00189	CcSEcCtD
Trandolapril—CES1—E2F transcription factor network—SERPINE1—atherosclerosis	0.000166	0.00397	CbGpPWpGaD
Trandolapril—Dysgeusia—Pravastatin—atherosclerosis	0.000165	0.00189	CcSEcCtD
Trandolapril—Muscle spasms—Niacin—atherosclerosis	0.000165	0.00188	CcSEcCtD
Trandolapril—Discomfort—Ezetimibe—atherosclerosis	0.000165	0.00188	CcSEcCtD
Trandolapril—Constipation—Rosuvastatin—atherosclerosis	0.000164	0.00188	CcSEcCtD
Trandolapril—Dry mouth—Ezetimibe—atherosclerosis	0.000163	0.00186	CcSEcCtD
Trandolapril—Muscle spasms—Pravastatin—atherosclerosis	0.000162	0.00185	CcSEcCtD
Trandolapril—Infection—Lovastatin—atherosclerosis	0.000162	0.00185	CcSEcCtD
Trandolapril—Thrombocytopenia—Lovastatin—atherosclerosis	0.00016	0.00182	CcSEcCtD
Trandolapril—Myalgia—Simvastatin—atherosclerosis	0.000159	0.00182	CcSEcCtD
Trandolapril—Arthralgia—Simvastatin—atherosclerosis	0.000159	0.00182	CcSEcCtD
Trandolapril—Chest pain—Simvastatin—atherosclerosis	0.000159	0.00182	CcSEcCtD
Trandolapril—Infection—Ezetimibe—atherosclerosis	0.000159	0.00181	CcSEcCtD
Trandolapril—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000158	0.00181	CcSEcCtD
Trandolapril—Anxiety—Simvastatin—atherosclerosis	0.000158	0.00181	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—HMOX1—atherosclerosis	0.000158	0.00379	CbGpPWpGaD
Trandolapril—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000157	0.0018	CcSEcCtD
Trandolapril—Discomfort—Simvastatin—atherosclerosis	0.000157	0.00179	CcSEcCtD
Trandolapril—Nervous system disorder—Ezetimibe—atherosclerosis	0.000157	0.00179	CcSEcCtD
Trandolapril—Angioedema—Niacin—atherosclerosis	0.000157	0.00179	CcSEcCtD
Trandolapril—Ill-defined disorder—Pravastatin—atherosclerosis	0.000157	0.00179	CcSEcCtD
Trandolapril—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000157	0.00179	CcSEcCtD
Trandolapril—Anaemia—Pravastatin—atherosclerosis	0.000156	0.00178	CcSEcCtD
Trandolapril—Anorexia—Lovastatin—atherosclerosis	0.000155	0.00177	CcSEcCtD
Trandolapril—Skin disorder—Ezetimibe—atherosclerosis	0.000155	0.00177	CcSEcCtD
Trandolapril—Angioedema—Pravastatin—atherosclerosis	0.000154	0.00176	CcSEcCtD
Trandolapril—Vertigo—Niacin—atherosclerosis	0.000154	0.00176	CcSEcCtD
Trandolapril—Syncope—Niacin—atherosclerosis	0.000154	0.00176	CcSEcCtD
Trandolapril—Leukopenia—Niacin—atherosclerosis	0.000154	0.00175	CcSEcCtD
Trandolapril—Urticaria—Rosuvastatin—atherosclerosis	0.000153	0.00174	CcSEcCtD
Trandolapril—Oedema—Simvastatin—atherosclerosis	0.000152	0.00174	CcSEcCtD
Trandolapril—Malaise—Pravastatin—atherosclerosis	0.000152	0.00174	CcSEcCtD
Trandolapril—Abdominal pain—Rosuvastatin—atherosclerosis	0.000152	0.00174	CcSEcCtD
Trandolapril—Vertigo—Pravastatin—atherosclerosis	0.000152	0.00173	CcSEcCtD
Trandolapril—Palpitations—Niacin—atherosclerosis	0.000152	0.00173	CcSEcCtD
Trandolapril—Infection—Simvastatin—atherosclerosis	0.000151	0.00173	CcSEcCtD
Trandolapril—Leukopenia—Pravastatin—atherosclerosis	0.000151	0.00173	CcSEcCtD
Trandolapril—Loss of consciousness—Niacin—atherosclerosis	0.000151	0.00172	CcSEcCtD
Trandolapril—Enalapril—ACE—atherosclerosis	0.00015	0.0463	CrCbGaD
Trandolapril—Cough—Niacin—atherosclerosis	0.00015	0.00171	CcSEcCtD
Trandolapril—Thrombocytopenia—Simvastatin—atherosclerosis	0.000149	0.0017	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000148	0.0017	CcSEcCtD
Trandolapril—Insomnia—Lovastatin—atherosclerosis	0.000147	0.00168	CcSEcCtD
Trandolapril—Cough—Pravastatin—atherosclerosis	0.000147	0.00168	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—GSTM1—atherosclerosis	0.000147	0.00353	CbGpPWpGaD
Trandolapril—Paraesthesia—Lovastatin—atherosclerosis	0.000146	0.00167	CcSEcCtD
Trandolapril—Arthralgia—Niacin—atherosclerosis	0.000146	0.00167	CcSEcCtD
Trandolapril—Myalgia—Niacin—atherosclerosis	0.000146	0.00167	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000146	0.00166	CcSEcCtD
Trandolapril—Anorexia—Simvastatin—atherosclerosis	0.000145	0.00166	CcSEcCtD
Trandolapril—Dyspnoea—Lovastatin—atherosclerosis	0.000145	0.00166	CcSEcCtD
Trandolapril—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000145	0.00166	CcSEcCtD
Trandolapril—Insomnia—Ezetimibe—atherosclerosis	0.000145	0.00165	CcSEcCtD
Trandolapril—Arthralgia—Pravastatin—atherosclerosis	0.000144	0.00164	CcSEcCtD
Trandolapril—Myalgia—Pravastatin—atherosclerosis	0.000144	0.00164	CcSEcCtD
Trandolapril—Chest pain—Pravastatin—atherosclerosis	0.000144	0.00164	CcSEcCtD
Trandolapril—Paraesthesia—Ezetimibe—atherosclerosis	0.000144	0.00164	CcSEcCtD
Trandolapril—Dyspepsia—Lovastatin—atherosclerosis	0.000143	0.00164	CcSEcCtD
Trandolapril—Anxiety—Pravastatin—atherosclerosis	0.000143	0.00164	CcSEcCtD
Trandolapril—Dry mouth—Niacin—atherosclerosis	0.000143	0.00163	CcSEcCtD
Trandolapril—Dyspnoea—Ezetimibe—atherosclerosis	0.000143	0.00163	CcSEcCtD
Trandolapril—Discomfort—Pravastatin—atherosclerosis	0.000142	0.00162	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—AGER—atherosclerosis	0.000142	0.00341	CbGpPWpGaD
Trandolapril—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000142	0.00162	CcSEcCtD
Trandolapril—Decreased appetite—Lovastatin—atherosclerosis	0.000142	0.00162	CcSEcCtD
Trandolapril—Dyspepsia—Ezetimibe—atherosclerosis	0.000141	0.00161	CcSEcCtD
Trandolapril—Fatigue—Lovastatin—atherosclerosis	0.000141	0.0016	CcSEcCtD
Trandolapril—Oedema—Niacin—atherosclerosis	0.00014	0.0016	CcSEcCtD
Trandolapril—Constipation—Lovastatin—atherosclerosis	0.000139	0.00159	CcSEcCtD
Trandolapril—Decreased appetite—Ezetimibe—atherosclerosis	0.000139	0.00159	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000139	0.00159	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000138	0.00158	CcSEcCtD
Trandolapril—Asthenia—Rosuvastatin—atherosclerosis	0.000138	0.00158	CcSEcCtD
Trandolapril—Insomnia—Simvastatin—atherosclerosis	0.000138	0.00157	CcSEcCtD
Trandolapril—Oedema—Pravastatin—atherosclerosis	0.000138	0.00157	CcSEcCtD
Trandolapril—Fatigue—Ezetimibe—atherosclerosis	0.000138	0.00157	CcSEcCtD
Trandolapril—Shock—Niacin—atherosclerosis	0.000138	0.00157	CcSEcCtD
Trandolapril—Infection—Pravastatin—atherosclerosis	0.000137	0.00156	CcSEcCtD
Trandolapril—Paraesthesia—Simvastatin—atherosclerosis	0.000137	0.00156	CcSEcCtD
Trandolapril—Constipation—Ezetimibe—atherosclerosis	0.000137	0.00156	CcSEcCtD
Trandolapril—Tachycardia—Niacin—atherosclerosis	0.000137	0.00156	CcSEcCtD
Trandolapril—Pruritus—Rosuvastatin—atherosclerosis	0.000136	0.00155	CcSEcCtD
Trandolapril—Skin disorder—Niacin—atherosclerosis	0.000136	0.00155	CcSEcCtD
Trandolapril—Dyspnoea—Simvastatin—atherosclerosis	0.000136	0.00155	CcSEcCtD
Trandolapril—Hyperhidrosis—Niacin—atherosclerosis	0.000135	0.00155	CcSEcCtD
Trandolapril—Thrombocytopenia—Pravastatin—atherosclerosis	0.000135	0.00154	CcSEcCtD
Trandolapril—Feeling abnormal—Lovastatin—atherosclerosis	0.000134	0.00153	CcSEcCtD
Trandolapril—Dyspepsia—Simvastatin—atherosclerosis	0.000134	0.00153	CcSEcCtD
Trandolapril—Anorexia—Niacin—atherosclerosis	0.000133	0.00152	CcSEcCtD
Trandolapril—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000133	0.00152	CcSEcCtD
Trandolapril—Hyperhidrosis—Pravastatin—atherosclerosis	0.000133	0.00152	CcSEcCtD
Trandolapril—Decreased appetite—Simvastatin—atherosclerosis	0.000133	0.00151	CcSEcCtD
Trandolapril—Feeling abnormal—Ezetimibe—atherosclerosis	0.000132	0.0015	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000132	0.0015	CcSEcCtD
Trandolapril—Diarrhoea—Rosuvastatin—atherosclerosis	0.000132	0.0015	CcSEcCtD
Trandolapril—Fatigue—Simvastatin—atherosclerosis	0.000131	0.0015	CcSEcCtD
Trandolapril—Anorexia—Pravastatin—atherosclerosis	0.000131	0.0015	CcSEcCtD
Trandolapril—Hypotension—Niacin—atherosclerosis	0.000131	0.00149	CcSEcCtD
Trandolapril—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000131	0.00149	CcSEcCtD
Trandolapril—Constipation—Simvastatin—atherosclerosis	0.00013	0.00149	CcSEcCtD
Trandolapril—Urticaria—Lovastatin—atherosclerosis	0.000129	0.00148	CcSEcCtD
Trandolapril—Abdominal pain—Lovastatin—atherosclerosis	0.000129	0.00147	CcSEcCtD
Trandolapril—Body temperature increased—Lovastatin—atherosclerosis	0.000129	0.00147	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000128	0.00146	CcSEcCtD
Trandolapril—Dizziness—Rosuvastatin—atherosclerosis	0.000127	0.00145	CcSEcCtD
Trandolapril—Urticaria—Ezetimibe—atherosclerosis	0.000127	0.00145	CcSEcCtD
Trandolapril—CES1—NRF2 pathway—PDGFB—atherosclerosis	0.000127	0.00304	CbGpPWpGaD
Trandolapril—Insomnia—Niacin—atherosclerosis	0.000127	0.00145	CcSEcCtD
Trandolapril—Body temperature increased—Ezetimibe—atherosclerosis	0.000126	0.00144	CcSEcCtD
Trandolapril—Abdominal pain—Ezetimibe—atherosclerosis	0.000126	0.00144	CcSEcCtD
Trandolapril—Paraesthesia—Niacin—atherosclerosis	0.000126	0.00144	CcSEcCtD
Trandolapril—Feeling abnormal—Simvastatin—atherosclerosis	0.000126	0.00143	CcSEcCtD
Trandolapril—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000126	0.00143	CcSEcCtD
Trandolapril—Dyspnoea—Niacin—atherosclerosis	0.000125	0.00143	CcSEcCtD
Trandolapril—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000125	0.00142	CcSEcCtD
Trandolapril—Insomnia—Pravastatin—atherosclerosis	0.000125	0.00142	CcSEcCtD
Trandolapril—Somnolence—Niacin—atherosclerosis	0.000124	0.00142	CcSEcCtD
Trandolapril—Paraesthesia—Pravastatin—atherosclerosis	0.000124	0.00141	CcSEcCtD
Trandolapril—Dyspepsia—Niacin—atherosclerosis	0.000123	0.00141	CcSEcCtD
Trandolapril—Dyspnoea—Pravastatin—atherosclerosis	0.000123	0.0014	CcSEcCtD
Trandolapril—Decreased appetite—Niacin—atherosclerosis	0.000122	0.00139	CcSEcCtD
Trandolapril—Dyspepsia—Pravastatin—atherosclerosis	0.000121	0.00139	CcSEcCtD
Trandolapril—Rash—Rosuvastatin—atherosclerosis	0.000121	0.00138	CcSEcCtD
Trandolapril—Dermatitis—Rosuvastatin—atherosclerosis	0.000121	0.00138	CcSEcCtD
Trandolapril—Urticaria—Simvastatin—atherosclerosis	0.000121	0.00138	CcSEcCtD
Trandolapril—Gastrointestinal disorder—Niacin—atherosclerosis	0.000121	0.00138	CcSEcCtD
Trandolapril—Abdominal pain—Simvastatin—atherosclerosis	0.000121	0.00138	CcSEcCtD
Trandolapril—Body temperature increased—Simvastatin—atherosclerosis	0.000121	0.00138	CcSEcCtD
Trandolapril—Headache—Rosuvastatin—atherosclerosis	0.00012	0.00138	CcSEcCtD
Trandolapril—Hypersensitivity—Lovastatin—atherosclerosis	0.00012	0.00137	CcSEcCtD
Trandolapril—Decreased appetite—Pravastatin—atherosclerosis	0.00012	0.00137	CcSEcCtD
Trandolapril—Fatigue—Pravastatin—atherosclerosis	0.000119	0.00136	CcSEcCtD
Trandolapril—Constipation—Pravastatin—atherosclerosis	0.000118	0.00135	CcSEcCtD
Trandolapril—Hypersensitivity—Ezetimibe—atherosclerosis	0.000118	0.00135	CcSEcCtD
Trandolapril—Asthenia—Lovastatin—atherosclerosis	0.000117	0.00134	CcSEcCtD
Trandolapril—Pruritus—Lovastatin—atherosclerosis	0.000115	0.00132	CcSEcCtD
Trandolapril—Asthenia—Ezetimibe—atherosclerosis	0.000115	0.00131	CcSEcCtD
Trandolapril—Gastrointestinal pain—Niacin—atherosclerosis	0.000114	0.00131	CcSEcCtD
Trandolapril—Nausea—Rosuvastatin—atherosclerosis	0.000114	0.0013	CcSEcCtD
Trandolapril—Feeling abnormal—Pravastatin—atherosclerosis	0.000114	0.0013	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000113	0.00272	CbGpPWpGaD
Trandolapril—Pruritus—Ezetimibe—atherosclerosis	0.000113	0.00129	CcSEcCtD
Trandolapril—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000113	0.00129	CcSEcCtD
Trandolapril—Hypersensitivity—Simvastatin—atherosclerosis	0.000112	0.00128	CcSEcCtD
Trandolapril—Diarrhoea—Lovastatin—atherosclerosis	0.000112	0.00127	CcSEcCtD
Trandolapril—Nateglinide—PPARG—atherosclerosis	0.000111	0.0344	CrCbGaD
Trandolapril—Urticaria—Niacin—atherosclerosis	0.000111	0.00127	CcSEcCtD
Trandolapril—Abdominal pain—Niacin—atherosclerosis	0.000111	0.00126	CcSEcCtD
Trandolapril—Body temperature increased—Niacin—atherosclerosis	0.000111	0.00126	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—PLA2G7—atherosclerosis	0.00011	0.00263	CbGpPWpGaD
Trandolapril—Urticaria—Pravastatin—atherosclerosis	0.000109	0.00125	CcSEcCtD
Trandolapril—Asthenia—Simvastatin—atherosclerosis	0.000109	0.00125	CcSEcCtD
Trandolapril—Diarrhoea—Ezetimibe—atherosclerosis	0.000109	0.00125	CcSEcCtD
Trandolapril—Body temperature increased—Pravastatin—atherosclerosis	0.000109	0.00124	CcSEcCtD
Trandolapril—Abdominal pain—Pravastatin—atherosclerosis	0.000109	0.00124	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000109	0.00261	CbGpPWpGaD
Trandolapril—Pruritus—Simvastatin—atherosclerosis	0.000108	0.00123	CcSEcCtD
Trandolapril—Dizziness—Lovastatin—atherosclerosis	0.000108	0.00123	CcSEcCtD
Trandolapril—Dizziness—Ezetimibe—atherosclerosis	0.000106	0.00121	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCG4—atherosclerosis	0.000105	0.00252	CbGpPWpGaD
Trandolapril—Diarrhoea—Simvastatin—atherosclerosis	0.000104	0.00119	CcSEcCtD
Trandolapril—Vomiting—Lovastatin—atherosclerosis	0.000104	0.00118	CcSEcCtD
Trandolapril—Hypersensitivity—Niacin—atherosclerosis	0.000103	0.00118	CcSEcCtD
Trandolapril—Rash—Lovastatin—atherosclerosis	0.000103	0.00117	CcSEcCtD
Trandolapril—Dermatitis—Lovastatin—atherosclerosis	0.000103	0.00117	CcSEcCtD
Trandolapril—Headache—Lovastatin—atherosclerosis	0.000102	0.00117	CcSEcCtD
Trandolapril—Vomiting—Ezetimibe—atherosclerosis	0.000102	0.00116	CcSEcCtD
Trandolapril—Hypersensitivity—Pravastatin—atherosclerosis	0.000102	0.00116	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCG8—atherosclerosis	0.000101	0.00242	CbGpPWpGaD
Trandolapril—Dizziness—Simvastatin—atherosclerosis	0.000101	0.00115	CcSEcCtD
Trandolapril—Rash—Ezetimibe—atherosclerosis	0.000101	0.00115	CcSEcCtD
Trandolapril—Dermatitis—Ezetimibe—atherosclerosis	0.000101	0.00115	CcSEcCtD
Trandolapril—Asthenia—Niacin—atherosclerosis	0.0001	0.00115	CcSEcCtD
Trandolapril—Headache—Ezetimibe—atherosclerosis	0.0001	0.00114	CcSEcCtD
Trandolapril—Pruritus—Niacin—atherosclerosis	9.9e-05	0.00113	CcSEcCtD
Trandolapril—Asthenia—Pravastatin—atherosclerosis	9.89e-05	0.00113	CcSEcCtD
Trandolapril—Pruritus—Pravastatin—atherosclerosis	9.75e-05	0.00111	CcSEcCtD
Trandolapril—Vomiting—Simvastatin—atherosclerosis	9.69e-05	0.00111	CcSEcCtD
Trandolapril—Nausea—Lovastatin—atherosclerosis	9.68e-05	0.00111	CcSEcCtD
Trandolapril—Rash—Simvastatin—atherosclerosis	9.61e-05	0.0011	CcSEcCtD
Trandolapril—Dermatitis—Simvastatin—atherosclerosis	9.6e-05	0.0011	CcSEcCtD
Trandolapril—Diarrhoea—Niacin—atherosclerosis	9.58e-05	0.00109	CcSEcCtD
Trandolapril—Headache—Simvastatin—atherosclerosis	9.55e-05	0.00109	CcSEcCtD
Trandolapril—Nausea—Ezetimibe—atherosclerosis	9.5e-05	0.00108	CcSEcCtD
Trandolapril—Diarrhoea—Pravastatin—atherosclerosis	9.43e-05	0.00108	CcSEcCtD
Trandolapril—Dizziness—Niacin—atherosclerosis	9.26e-05	0.00106	CcSEcCtD
Trandolapril—Dizziness—Pravastatin—atherosclerosis	9.11e-05	0.00104	CcSEcCtD
Trandolapril—Nausea—Simvastatin—atherosclerosis	9.06e-05	0.00103	CcSEcCtD
Trandolapril—ACE—Metabolism of proteins—HSPD1—atherosclerosis	8.92e-05	0.00214	CbGpPWpGaD
Trandolapril—Vomiting—Niacin—atherosclerosis	8.9e-05	0.00102	CcSEcCtD
Trandolapril—Rash—Niacin—atherosclerosis	8.83e-05	0.00101	CcSEcCtD
Trandolapril—Dermatitis—Niacin—atherosclerosis	8.82e-05	0.00101	CcSEcCtD
Trandolapril—Headache—Niacin—atherosclerosis	8.77e-05	0.001	CcSEcCtD
Trandolapril—Vomiting—Pravastatin—atherosclerosis	8.76e-05	0.001	CcSEcCtD
Trandolapril—Rash—Pravastatin—atherosclerosis	8.69e-05	0.000992	CcSEcCtD
Trandolapril—Dermatitis—Pravastatin—atherosclerosis	8.68e-05	0.000992	CcSEcCtD
Trandolapril—Headache—Pravastatin—atherosclerosis	8.63e-05	0.000986	CcSEcCtD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCG1—atherosclerosis	8.6e-05	0.00206	CbGpPWpGaD
Trandolapril—Nausea—Niacin—atherosclerosis	8.32e-05	0.00095	CcSEcCtD
Trandolapril—Nausea—Pravastatin—atherosclerosis	8.19e-05	0.000935	CcSEcCtD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCG1—atherosclerosis	7.98e-05	0.00191	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	7.79e-05	0.00187	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	7.23e-05	0.00173	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—F7—atherosclerosis	7.19e-05	0.00172	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—TRPV1—atherosclerosis	7.01e-05	0.00168	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ABCG5—atherosclerosis	6.75e-05	0.00162	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—TRPV1—atherosclerosis	6.5e-05	0.00156	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—GHRL—atherosclerosis	6.41e-05	0.00154	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ABCG5—atherosclerosis	6.26e-05	0.0015	CbGpPWpGaD
Trandolapril—CES1—NRF2 pathway—TGFB1—atherosclerosis	6e-05	0.00144	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PLAUR—atherosclerosis	5.58e-05	0.00134	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—PLG—atherosclerosis	5.45e-05	0.00131	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—CETP—atherosclerosis	4.99e-05	0.0012	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—IGF2—atherosclerosis	4.96e-05	0.00119	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—CETP—atherosclerosis	4.63e-05	0.00111	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.4e-05	0.00106	CbGpPWpGaD
Trandolapril—Nateglinide—ALB—atherosclerosis	4.19e-05	0.0129	CrCbGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—PLAT—atherosclerosis	4.08e-05	0.000979	CbGpPWpGaD
Trandolapril—SLC15A2—SLC-mediated transmembrane transport—ALB—atherosclerosis	4.08e-05	0.000979	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—MMP1—atherosclerosis	3.98e-05	0.000955	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—AGT—atherosclerosis	3.93e-05	0.000944	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—LEP—atherosclerosis	3.86e-05	0.000925	CbGpPWpGaD
Trandolapril—SLC15A1—SLC-mediated transmembrane transport—ALB—atherosclerosis	3.79e-05	0.000908	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—PLG—atherosclerosis	3.74e-05	0.000897	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—F2—atherosclerosis	3.64e-05	0.000872	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—PLG—atherosclerosis	3.47e-05	0.000833	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.45e-05	0.000828	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—APOB—atherosclerosis	3.31e-05	0.000793	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—INS—atherosclerosis	3.29e-05	0.00079	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—CCL2—atherosclerosis	3.24e-05	0.000777	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	3.21e-05	0.000769	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—IGF1—atherosclerosis	3.19e-05	0.000764	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—MMP2—atherosclerosis	3.08e-05	0.000739	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—APOB—atherosclerosis	3.07e-05	0.000736	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.79e-05	0.000669	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.62e-05	0.000628	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.59e-05	0.000621	CbGpPWpGaD
Trandolapril—ACE—Metabolism of proteins—CXCL8—atherosclerosis	2.56e-05	0.000614	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.43e-05	0.000582	CbGpPWpGaD
Trandolapril—SLC15A2—Transmembrane transport of small molecules—ALB—atherosclerosis	2.07e-05	0.000497	CbGpPWpGaD
Trandolapril—SLC15A1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.92e-05	0.000462	CbGpPWpGaD
